RADAR-AD clinical study officially starts

The first participant to take part in the RADAR-AD study was included on 10 July in the project’s clinical site in Thessaloniki, Greece. Although the participant was recruited from the Medical School of Aristotle University, the RADAR-AD Greek team scheduled the appointment at the GAADRD’s facilities for participants’ and researchers’ convenience. This first visit marks the start of the remote monitoring trial of the RADAR-AD project. It is very important to see whether RADAR-AD can effectively collect data from participants remotely and be able to assess their functional and cognitive status.

In the upcoming weeks the RADAR-AD consortium expects more inclusions to follow at its other clinical sites.

RADAR-AD’s project co-lead Dag Aarsland from King’s College London shares:

‘The RADAR-AD Consortium is delighted to announce that July saw the first participant enrolled into RADAR-AD study. Despite the COVID-19 pandemic resulting in RADAR-AD centres across Europe having to suspend recruitment, our colleagues in Thessaloniki, Greece, are the first to able to begin recruitment. After some understandable delays, most other RADAR-AD centres are ready to follow at short notice, as soon as each clinical site is cleared to re-start clinical studies from the relevant regional governing bodies.’